155 related articles for article (PubMed ID: 18716000)
1. Structural basis of Clostridium perfringens toxin complex formation.
Adams JJ; Gregg K; Bayer EA; Boraston AB; Smith SP
Proc Natl Acad Sci U S A; 2008 Aug; 105(34):12194-9. PubMed ID: 18716000
[TBL] [Abstract][Full Text] [Related]
2. The solution structure of the C-terminal modular pair from Clostridium perfringens mu-toxin reveals a noncellulosomal dockerin module.
Chitayat S; Adams JJ; Furness HS; Bayer EA; Smith SP
J Mol Biol; 2008 Sep; 381(5):1202-12. PubMed ID: 18602403
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional structure of a putative non-cellulosomal cohesin module from a Clostridium perfringens family 84 glycoside hydrolase.
Chitayat S; Gregg K; Adams JJ; Ficko-Blean E; Bayer EA; Boraston AB; Smith SP
J Mol Biol; 2008 Jan; 375(1):20-8. PubMed ID: 17999932
[TBL] [Abstract][Full Text] [Related]
4. Mechanical Stability of a High-Affinity Toxin Anchor from the Pathogen Clostridium perfringens.
Milles LF; Bayer EA; Nash MA; Gaub HE
J Phys Chem B; 2017 Apr; 121(15):3620-3625. PubMed ID: 27991799
[TBL] [Abstract][Full Text] [Related]
5. NMR assignment of backbone and side chain resonances for a dockerin-containing C-terminal fragment of the putative mu-toxin from Clostridium perfringens.
Chitayat S; Adams JJ; Smith SP
Biomol NMR Assign; 2007 Jul; 1(1):13-5. PubMed ID: 19636814
[TBL] [Abstract][Full Text] [Related]
6. Molecular and cellular basis of microvascular perfusion deficits induced by Clostridium perfringens and Clostridium septicum.
Hickey MJ; Kwan RY; Awad MM; Kennedy CL; Young LF; Hall P; Cordner LM; Lyras D; Emmins JJ; Rood JI
PLoS Pathog; 2008 Apr; 4(4):e1000045. PubMed ID: 18404211
[TBL] [Abstract][Full Text] [Related]
7. The first strain of Clostridium perfringens isolated from an avian source has an alpha-toxin with divergent structural and kinetic properties.
Justin N; Walker N; Bullifent HL; Songer G; Bueschel DM; Jost H; Naylor C; Miller J; Moss DS; Titball RW; Basak AK
Biochemistry; 2002 May; 41(20):6253-62. PubMed ID: 12009886
[TBL] [Abstract][Full Text] [Related]
8. Clostridium perfringens beta toxin and Clostridium septicum alpha toxin: their mechanisms and possible role in pathogenesis.
Tweten RK
Vet Microbiol; 2001 Sep; 82(1):1-9. PubMed ID: 11423190
[TBL] [Abstract][Full Text] [Related]
9. Differential conformational environment of tryptophan in epsilon native prototoxin and active toxin from Clostridium perfringens type D.
Kumar A; Kumar S; Sarma Dagger PV; Sharma Double Dagger AK
J Biochem Mol Biol Biophys; 2002 Apr; 6(2):147-50. PubMed ID: 12186772
[TBL] [Abstract][Full Text] [Related]
10. The enteric toxins of Clostridium perfringens.
Smedley JG; Fisher DJ; Sayeed S; Chakrabarti G; McClane BA
Rev Physiol Biochem Pharmacol; 2004; 152():183-204. PubMed ID: 15517462
[TBL] [Abstract][Full Text] [Related]
11. Opening of the active site of Clostridium perfringens alpha-toxin may be triggered by membrane binding.
Titball RW; Naylor CE; Miller J; Moss DS; Basak AK
Int J Med Microbiol; 2000 Oct; 290(4-5):357-61. PubMed ID: 11111911
[TBL] [Abstract][Full Text] [Related]
12. Roles of the carboxy-terminal region of Clostridium perfringens alpha toxin.
Nagahama M; Iida H; Nishioka E; Okamoto K; Sakurai J
FEMS Microbiol Lett; 1994 Jul; 120(3):297-301. PubMed ID: 8076805
[TBL] [Abstract][Full Text] [Related]
13. Insights into higher-order organization of the cellulosome revealed by a dissect-and-build approach: crystal structure of interacting Clostridium thermocellum multimodular components.
Adams JJ; Currie MA; Ali S; Bayer EA; Jia Z; Smith SP
J Mol Biol; 2010 Mar; 396(4):833-9. PubMed ID: 20070943
[TBL] [Abstract][Full Text] [Related]
14. Cellular Entry of Clostridium perfringens Iota-Toxin and Clostridium botulinum C2 Toxin.
Takehara M; Takagishi T; Seike S; Oda M; Sakaguchi Y; Hisatsune J; Ochi S; Kobayashi K; Nagahama M
Toxins (Basel); 2017 Aug; 9(8):. PubMed ID: 28800062
[No Abstract] [Full Text] [Related]
15. Dissecting the contributions of Clostridium perfringens type C toxins to lethality in the mouse intravenous injection model.
Fisher DJ; Fernandez-Miyakawa ME; Sayeed S; Poon R; Adams V; Rood JI; Uzal FA; McClane BA
Infect Immun; 2006 Sep; 74(9):5200-10. PubMed ID: 16926413
[TBL] [Abstract][Full Text] [Related]
16. Site-specific mutagenesis of Clostridium perfringens alpha-toxin: replacement of Asp-56, Asp-130, or Glu-152 causes loss of enzymatic and hemolytic activities.
Nagahama M; Nakayama T; Michiue K; Sakurai J
Infect Immun; 1997 Aug; 65(8):3489-92. PubMed ID: 9234819
[TBL] [Abstract][Full Text] [Related]
17. A novel toxin homologous to large clostridial cytotoxins found in culture supernatant of Clostridium perfringens type C.
Amimoto K; Noro T; Oishi E; Shimizu M
Microbiology (Reading); 2007 Apr; 153(Pt 4):1198-1206. PubMed ID: 17379729
[TBL] [Abstract][Full Text] [Related]
18. Generation of recombinant baculovirus expressing atoxic C-terminal CPA toxin of Clostridium perfringens and production of specific antibodies.
Forti K; Cagiola M; Pellegrini M; Anzalone L; Di Paolo A; Corneli S; Severi G; De Giuseppe A
BMC Biotechnol; 2020 Jan; 20(1):7. PubMed ID: 31992276
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of a cohesin module from Clostridium cellulolyticum: implications for dockerin recognition.
Spinelli S; Fiérobe HP; Belaïch A; Belaïch JP; Henrissat B; Cambillau C
J Mol Biol; 2000 Nov; 304(2):189-200. PubMed ID: 11080455
[TBL] [Abstract][Full Text] [Related]
20. Purification, crystallization and preliminary X-ray diffraction studies of alpha-toxin of Clostridium perfringens.
Basak AK; Stuart DI; Nikura T; Bishop DH; Kelly DC; Fearn A; Titball RW
J Mol Biol; 1994 Dec; 244(5):648-50. PubMed ID: 7990145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
